Browsing by Author "Chambers G"

Now showing 1 - 5 of 5

An observational study of farmer-reported clinical mastitis in New Zealand dairy ewes.
(Taylor and Francis Group, 2024-07-01) Chambers G; Laven R; Grinberg A; Ridler A; Velathanthiri N
AIMS: To describe the incidence, aetiology, treatment, and outcomes of farmer-reported clinical mastitis on New Zealand dairy sheep farms. METHODS: A prospective cohort study was conducted on 20 spring-lambing New Zealand sheep milking farms over the 2022-2023 season. Clinical mastitis was defined as a change in the appearance of milk and/or signs of inflammation in the gland. Farmers were required to report all cases of clinical mastitis and collect information on affected ewes' demographics, clinical features, treatments (where applicable), and outcomes. Milk samples from mastitic glands were submitted for microbiological culture and identification by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF). RESULTS: Partial or complete clinical mastitis data were available for 236 cases from 221 ewes on 18/20 study farms. Clinical mastitis was diagnosed in 0-6% of ewes at the farm level, with an overall incidence of 1.8 (95% CI = 1.0-3.2)% using the study data, or 2.3 (95% CI = 1.6-3.3)% using the study data and farmer estimates that included unreported cases. Cases occurred mostly in early lactation, with 59% detected during the lambing period (August-October), at a median of 7 (IQR 3, 40) days in milk. The majority of cases featured clots in the milk (59%), swelling (55%), and unevenness (71%) of the glands. Pyrexia (rectal temperature ≥ 40.0°C) was diagnosed in 25% of cases and depression (lethargy, inappetence, or inability to stand) in 26% of cases. Treatment was given to 46% of cases, with tylosin being the most commonly used treatment (50% of treated cases). The most common outcome was immediate drying off to be culled without treatment (32%), followed by still milking and recovered but with lasting problems (25%). Nearly half of all the milk samples submitted were culture negative. Streptococcus uberis (14%), non-aureus staphylococci (12%), and Staphylococcus aureus (11%) were the most common isolates, found on 12, 8 and 8 of the 16 farms with microbiological data, respectively. CONCLUSIONS: Clinical mastitis affected up to 6% of ewes at the farm level. Systemic signs were observed in one quarter of affected ewes, suggesting a role for supportive treatment. Clinical mastitis can be severe and challenging to fully resolve in New Zealand dairy sheep. CLINICAL RELEVANCE: This is the first systematic study of clinical mastitis in New Zealand dairy ewes. It provides baseline information specific to New Zealand conditions for farmers, veterinarians, and other advisors to guide the management of mastitis for the relatively new dairy sheep industry in New Zealand.
Subclinical mastitis in New Zealand grazing dairy ewes 1: Prevalence and risk factors
(Elsevier Inc on behalf of the American Dairy Science Association, 2026-01-01) Chambers G; Lawrence K; Grinberg A; Velathanthiri N; Ridler A; Laven R
Our objectives were to describe subclinical mastitis and identify its risk factors among grazing dairy ewes in New Zealand. Gland-level milk samples were collected from ∼15 randomly selected ewes on each of 20 dairy sheep farms at early, mid, and late lactation in a repeated cross-sectional study. California Mastitis Tests (CMT; measured on a scale of 0, trace, 1, 2, or 3) and aerobic bacterial culture were performed at the gland level, and SCC at the ewe level using composite milk samples. Subclinical mastitis was defined at the ewe level as having 1 or 2 bacteriologically positive glands and SCC >500 × 103 cells/mL or a CMT score ≥1 (or both). Milk samples were collected from 893 ewes, and complete subclinical mastitis data were available for 856 ewes. Median (range) SCC was 128,000 (2,000–34,953,000) cells/mL. A CMT score ≥1 in one or both glands was found in 21.2% of ewes. Bacteria were isolated from 5.5% of glands, with the most common species being non-aureus staphylococci (4.0% of glands) and Staphylococcus aureus (0.6% of glands). The prevalence of subclinical mastitis was 6.4% (95% CI = 4.6%–8.7%) and was not strongly clustered within farms (intraclass correlation coefficient = 0.04). Ewes with moderate or severe teat end hyperkeratosis had 6.4 times higher odds of subclinical mastitis than ewes with no or mild hyperkeratosis, and ewes with asymmetric udders had 2.3 times higher odds. The odds declined across the 3 visits. The prevalence was low compared with studies of more intensively farmed ewes in the northern hemisphere, but the bacterial causes were consistent. Subclinical mastitis management should be focused at the ewe level before the farm level, given the weak clustering within farms. When addressing or preventing a subclinical mastitis challenge, producers should consider teat end hyperkeratosis and udder asymmetry as simple visual screening tools but not rely on them alone to identify ewes at risk of subclinical mastitis. We present new information for New Zealand grazing dairy ewes, examine udder asymmetry as a diagnostic tool for subclinical mastitis, and show that, although prevalence was lower in New Zealand, the dominant pathogens are consistent, supporting the broader relevance of these findings to international mastitis control, albeit with adaptations for pasture-based systems.
Subclinical mastitis in New Zealand grazing dairy ewes 2: Relationships among somatic cell count, California Mastitis Test, and milk culture, and risk factors for elevated aerobic plate count
(Elsevier Inc on behalf of the American Dairy Science Association, 2026-01-01) Chambers G; Lawrence K; Grinberg A; Velathanthiri N; Ridler A; Laven R
Our objectives were, in grazing dairy ewes, (1) to describe SCC, California Mastitis Test (CMT) score, and ewe-level milk aerobic plate count (APC), (2) to explore the relationship between CMT and SCC, (3) to identify risk factors for elevated APC, and (4) to find the optimal SCC threshold for diagnosis of IMI. Gland-level milk samples were collected from ∼15 randomly selected ewes on each of 20 New Zealand dairy sheep farms at early, mid, and late lactation in a repeated cross-sectional study. Aerobic bacterial culture and CMT (measured on a scale of 0, trace, 1, 2, or 3) were performed at the gland level, and SCC and APC at the ewe level using composite milk samples. Milk samples were collected from 893 ewes, 870 of which had complete SCC and culture data. Geometric mean SCC was 169,039 (95% CI: 153,921–185,641) cells/mL, varying between farms and decreasing across visits. A CMT score ≥1 in one or both glands occurred in 21.2% of ewes. Mean log10 SCC increased linearly with CMT score, but the correlation between the ewe's highest gland-level CMT score and SCC was moderate (Kendall's tau = 0.47, 95% CI 0.43–0.52). Bacteria were isolated from 86 (9.9%) ewes, with the most common bacteria being NAS (7.0% of glands) and Staphylococcus aureus (0.6% of glands). A SCC threshold of ∼400,000 cells/mL had the greatest Youden's index for diagnosing IMI using a single SCC measurement. The APC was below the limit of quantification (1 × 103 cfu/mL) in 78.0% of ewes, and <100 × 103 cfu/mL in 96.9% of ewes, and varied between visits and farms. Using a mixed Bayesian ordinal regression model, elevated CMT score and SCC, positive milk culture, and subclinical mastitis, but not udder asymmetry, were confirmed as risk factors for elevated APC. These findings provide baseline milk quality data for New Zealand grazing dairy ewes, confirm that udder health should be considered when investigating elevated bulk milk APC, and can be used to help producers manage SCC, subclinical mastitis, and APC, as well as informing further research. Findings specific to New Zealand's emerging sheep dairy industry offer a benchmark for pastoral systems internationally and highlight the importance of udder health to bulk milk quality.
Teat and udder morphology and pathology of New Zealand dairy ewes.
(Taylor and Francis Group, 2025-02-12) Chambers G; Lawrence KE; Ridler AL; Laven RA
AIMS: To describe the morphology and prevalence of teat and udder pathology of New Zealand dairy ewes. METHODS: A repeated cross-sectional study was conducted on 20 commercial New Zealand dairy sheep farms over the 2022-2023 season. Approximately 15 randomly selected ewes were examined on each farm in early, mid, and late lactation. Four udder morphology measures were scored on a 5-point scale: depth (1 = pendulous, 5 = compact udder), suspension (ratio of width at abdominal attachment to height, 1 = low, 5 = high), gland separation (1 = zero, 5 = maximum separation), and teat placement (1 = distally located, vertically oriented, 5 = laterally located, horizontally oriented teats). Teat length and width were measured, and the presence of supernumerary teats, asymmetry, visible teat/udder inflammation, and lesions were recorded. Teats and glands were palpated for consistency, gland-nodules, teat canal thickening, and patency, and teat ends scored for hyperkeratosis. Teat and gland-level pathological variables were converted to ewe-level scores. The presence of involuted, non- or minimally lactating glands was recorded. Data were analysed using descriptive statistics. RESULTS: Across the three visits, 893 observations were made on 882 unique ewes. Mean teat length and width were 27.5 (95% CI = 27.2-27.7) and 15.8 (95% CI = 15.7-15.9) mm. Udder depth, separation, suspension, and teat placement had modal scores of 4, 3, 3, and 3 respectively, and varied across visits and age groups. Asymmetrical udder prevalence was 39% (95% CI = 35.5-42%) overall and increased with age (27% for 1-year-olds, 38% for two-year-olds, 43% for mixed age ewes). Supernumerary teats were observed in 15% (95% CI = 13-17.9%) of ewes. There was between-farm variation in all udder morphology variables. Ewe-level prevalences of teat end hyperkeratosis (any degree of severity), gland/teat inflammation, lesions, palpable defects, and involuted glands were all < 6%. CONCLUSIONS: Morphological observations resembled those from overseas dairy sheep. Teat dimensions, udder depth, separation, suspension, teat placement, and presence of supernumerary teats varied between farms. Udder depth, separation, and suspension scores decreased with age, while teat placement score and the prevalence of asymmetry increased with age. Teat and udder pathology were rare. CLINICAL RELEVANCE: This is the first systematic study of teat and udder morphology and pathology in New Zealand dairy ewes. The data will be useful for farmers and industry partners, providing a comparison with their own flocks, identifying areas for improvement, and informing and contrasting with future studies.
Use of hormones on New Zealand dairy farms: an analysis of the results from a survey of farmers and a survey of veterinarians
(Taylor and Francis Group on behalf of the New Zealand Veterinary Association, 2025-07-09) Laven RA; Cuttance EL; Chambers G
Aims: To survey New Zealand dairy farmers and veterinarians on their attitude and use of reproductive hormones in treating cows identified as non-cyclers. Whilst hormones have been identified as effective tools in assisting reproduction in dairy cattle, there is widespread but anecdotal concern about their cost-effectiveness and a lack of high-quality information on the attitude and practices around hormone use on New Zealand dairy farms. Methods: Electronic links to separate farmer and veterinary survey forms were sent to all dairy clients and all veterinary employees of five, convenience-selected veterinary practices across New Zealand. Using closed, open, and Likert-style questions, the surveys covered cost-effectiveness of hormonal interventions, value judgements on their use, and impact on the public perception of dairy farming. Results: Usable surveys were returned by 424 farmers and 70 veterinarians. Response rates are not known as denominator data were not sought. Of the farmers, 253/424 (60%) reported using hormone treatments, with 153 (36%) primarily using them before mating started. However, only 163 (38%) thought treatment was cost-effective, compared to 65/70 (93%) veterinarians. Beliefs around cost-effectiveness affected use: 8/171 (5%) farmers who never used hormones believed they were cost-effective, compared to 38/94 (40%) who used hormones occasionally and 117/159 (74%) who used them routinely. Other reasons put forward by farmers for not using hormones included “breeding infertility”, “not natural”, and “not treating the cause”. Farmer and veterinary opinion also varied around the trajectory of hormone use. Amongst veterinarians, 12/70 (17%) thought use should decrease compared to 271/424 (64%) farmers, while 19/70 (27%) veterinarians thought use should increase compared to 21/424 (5%) of farmers. Conclusions: The results suggest a disconnect around hormone use between the participating veterinarians and farmers. Many farmers did not believe hormone use was cost-effective, despite strong evidence to the contrary. As other reasons for not using hormones were also cited, and as most farmers believed hormone use should decrease, it seems unlikely that further education on cost-effectiveness will change practice. Rather, it could increase the proportion who think veterinarians benefit financially more from hormone use. Clinical relevance: Veterinary focus on maximising synchronisation use and efficacy is bypassing a significant proportion of dairy farmers. There is an opportunity for veterinarians to focus on what their clients want and work with them to improve herd fertility without relying on hormones to fix management problems.